Effectiveness and Implementation of a National Guideline for Acute Respiratory Tract Infections to Reduce Antibiotic Prescribing in Swiss Primary Care

Recruiting N/A Interventional Study
Acute Respiratory Infection Influenza-like Illness
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Interventional
Purpose
Diagnostic
Participants needed
200 (estimated)
Sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The ImpProGUIDE study aims to find out whether implementing new Swiss national guidelines for acute respiratory infections (ARI) can help to reduce antibiotic prescribing in primary care. In Switzerland, most antibiotics are prescribed in outpatient care, and many of these prescriptions may not be needed - especially when infections are caused by viruses, which antibiotics do not treat. Reducing o…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion criteria for quality circles (QCs) * Willing to participate in a study mainly conducted in French * Agreeing to participate in evaluation surveys Exclusion criteria for QCs\* \- Not having any physician included in the study Inclusion criteria for walk-in clinics * The clinic offers g…
Contacts

Jelena Dunaiceva, MPH

+41 78 654 23 74

jelena.dunaiceva@unisante.ch; imppro@unisante.ch

CONTACT